Coltene Holding AG (XSWX:CLTN) Current Deferred Revenue: CHF0.0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:CLTN Coltene Holding AG XSWX:CLTN
69 GF Score
Price CHF52.90
GF Value CHF55.12
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Coltene Holding AG Current Deferred Revenue?

Coltene Holding AG XSWX:CLTN +1.93% 69 Current Deferred Revenue is CHF0.0 Mil as of Dec. 2025. GuruFocus rates XSWX:CLTN with a GF Score™ of 69/100 and a GF Value™ of CHF55.12 (Fairly Valued). The stock has 3 warning signs investors should review.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Coltene Holding AG's current deferred revenue for the quarter that ended in Dec. 2025 was CHF0.0 Mil.

Coltene Holding AG Current Deferred Revenue Related Terms

Coltene Holding AG Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Coltene Holding AG's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Coltene Holding AG Current Deferred Revenue Chart

Coltene Holding AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Coltene Holding AG Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XSWX:CLTN
69GF Score
Coltene Holding AG XSWX:CLTN
Current Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Revenue of CHF0.0 Mil mean?
Coltene Holding AG (XSWX:CLTN) has a Current Deferred Revenue of CHF0.0 Mil as of Dec. 2025. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Coltene Holding AG and its competitors.
Is Coltene Holding AG's Current Deferred Revenue too high?
Coltene Holding AG's current Current Deferred Revenue is CHF0.0 Mil. Overall, Coltene Holding AG has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Coltene Holding AG's Current Deferred Revenue compare to ISRG and BDX?
Coltene Holding AG's Current Deferred Revenue of CHF0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Medical Devices & Instruments company?
A good Current Deferred Revenue depends on the Medical Devices & Instruments industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Coltene Holding AG and its competitors. Coltene Holding AG's current Current Deferred Revenue is CHF0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Coltene Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Coltene Holding AG (XSWX:CLTN) is currently considered Fairly Valued. The stock's GF Value™ is CHF55.12, compared to a current price of CHF52.90 — trading 4% below its estimated fair value. The current Current Deferred Revenue is CHF0.0 Mil. Coltene Holding AG's overall GF Score™ is 69/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For Coltene Holding AG (XSWX:CLTN), the current Current Deferred Revenue is CHF0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Coltene Holding AG (XSWX:CLTN) Overvalued in 2026?

Based on GuruFocus' analysis, Coltene Holding AG stock appears to be undervalued. The current stock price of CHF52.90 is trading 4% below its estimated GF Value™ of CHF55.12. GuruFocus considers Coltene Holding AG to be Fairly Valued.

Key valuation signals for XSWX:CLTN:

  • Current Deferred Revenue: CHF0.0 Mil
  • GF Value™: CHF55.12 vs. price of CHF52.90 (4% below fair value)
  • GF Score™: 69/100 with 3 warning signs

No single metric tells the full story. See the XSWX:CLTN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Coltene Holding AG Business Description

Other Exchanges CLTNz:UK0QP7:UKM3Z:Germany
Address Feldwiesenstrasse 20, Altstatten, CHE, 9450
Coltene Holding AG is a manufacturer and distributor of consumables and small devices for dental practices, dental service organisations (DSOs), dental clinics and laboratories, as well as for non-dental niches (e.g., clinics for ophthalmology or podiatry). The Group develops, manufactures, and sells mainly via distribution channels a broad and comprehensive range of disposables, tools, and equipment for dentists and dental laboratories. Geographically, it operates in EMEA, North America, Latin America, and Asia/Oceania, with maximum from North America.
69GF Score

Get the complete analysis for XSWX:CLTN

Current Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF52.90
Price
CHF55.12
GF Value